Imperial College Healthcare NHS Trust’s Post

Researchers have used artificial intelligence to provide a ‘virtual biopsy’ for cancer patients, in a study funded by NIHR Imperial Biomedical Research Centre ➡️ https://lnkd.in/e7rzRbqc This non-invasive method can classify the type of lung cancer and if the cancer is likely to progress. Professor Eric Aboagye, from Imperial College London's department of surgery and cancer, said: “This research shows the potential of using CT scans to gain a deeper, more nuanced understanding of tissue and tumour chemical composition, that has until now only been accessible through direct tissue sampling. This method could prove particularly beneficial in countries like the UK, where lung cancer prevalence is high, and potentially transform diagnostic and treatment protocols.” #LungCancer #Cancer #VirtualBiopsy NHS England

Did you know Medulloblastoma is the most common high-grade paediatric brain tumour, affecting around 52 children each year in the UK? Currently, surgery is needed to classify the tumour and determine treatment. Thanks to a study funded by Children with Cancer UK, Cancer Research UK, Children's Cancer North, scientists at Birmingham University have used MRI scans to identify the chemical signature of each tumour type. This groundbreaking research could allow for a brain tumour diagnosis in just 10 minutes! ⏱️ Want to find out more? Read here ➡️ https://bit.ly/3RqLm5z #Research #BrainTumourResearch #RaisingAwareness

Laparoscopic cholecystectomy frequently reveals gallbladder cancers (GBCs), often previously undiagnosed. Given the poor prognosis of GBC, understanding factors influencing outcomes is vital. A systematic review by Dr. Kavin Sugumar explores the prognostic significance of biliary spillage (BS)—the accidental leakage of bile during surgery—finding that BS might worsen survival rates by spreading cancer cells. These insights could reshape surgical practices and improve postoperative management for GBC patients. #TulaneResearch #Cancer #Oncology Read the paper in the comments! Image: Results from individual studies and aggregated data suggest bile spillage is associated with decreased overall survival.

🚀 #SpecialIssue Launch #CallforPaper: Diagnosis and Treatment of Malignant Tumors of the Chest 🚀 🔑Malignant thoracic tumors, including lung cancer, pleural mesothelioma, thymoma, and chest wall tumors, require a complex multidisciplinary approach for diagnosis and treatment. Lung cancer is a leading cause of cancer death, while other thoracic tumors, though rare, also have poor prognoses. This special issue focuses on current state-of-the-art practices and solicits contributions from surgery, oncology, and radiotherapy to define the best treatment pathways. 📅 Guest Editor: Prof. Francesco Petrella, Fondazione IRCCS San Gerardo dei Tintori, University of Milan, Italy. We invite your valuable participation and support in promoting this special issue! 👉 Read more and participate: https://lnkd.in/eBc33Ghz #MedicalResearch #ThoracicSurgery #OncologyResearch #Radiotherapy #MultidisciplinaryApproach #LungCancer #PleuralMesothelioma #Thymoma #ChestWallTumors #NeurogenicTumors #RareTumors #TechSciencePress

Revolutionizing pH Detection in Cancer Research – Discover the PHX Series Probes! 🌟   The subtle reverse transmembrane pH gradient in cancer cells is a critical target for treatment and intraoperative analysis. However, conventional pH fluorescent probes fall short in detecting these minimal yet significant changes.   Enter the PHX series – a breakthrough in highly sensitive Hill-type pH fluorescent probes, developed by Professor Yang Youjun’s team at East China University of Science and Technology.   💡 Why Choose PHX Series Probes? ✔️ Exceptional sensitivity for pH detection in diverse biological environments. ✔️ Ideal for detecting small dynamic pH changes in cancer cells and tissues. ✔️ Cutting-edge innovation for cancer diagnosis and fluorescence-guided surgery.   Now exclusively available at J&K Scientific!   🔗 Learn more about this groundbreaking product: https://lnkd.in/eJcHvD4p   #JKScientific #PHXProbes #CancerResearch #IntraoperativeAnalysis #BiomedicalInnovation #pHDetection #Bioimaging #CancerDiagnosis

In the latest episode of my podcast, “The Immuno-Oncology Curve,” I'm joined by my Agenus colleagues Dr. Joseph Grossman and Dr. Benny Johnson. We talk about why we left the practice of medicine for Agenus. And, we reflect on this year’s #ASCO GI Cancers Symposium, covering the rise of early-onset cancers, the promising use of circulating tumor DNA (ctDNA) as a biomarker, the ongoing challenge of diversity in cancer clinical trials, and the overall potential of I-O to reduce dependence on chemotherapy and surgery. Listen and subscribe at: https://bit.ly/4bNIAzJ

New review from The #FASEBJournal: Targeting KRAS in gynecological malignancies Cervical, endometrial, and ovarian cancers are among the most common gynecological malignancies and while surgery, chemotherapy, and radiotherapy are standard treatments, challenges like relapse and drug resistance persist. KRAS, one of the most frequently mutated oncogenes, plays a pivotal role in these cancers. This comprehensive review explores how KRAS serves as a biomarker and outlines emerging therapeutic strategies targeting the KRAS pathway in gynecological tumors. 📄 Read the full article to dive deeper into potential breakthroughs in cancer treatment: https://hubs.ly/Q02YcdP00 #CancerResearch #GynecologicalCancer #KRAS #Oncology #MedicalResearch #CancerTreatment #FASEB

August 1 is #WorldLungCancerDay. The American Cancer Society predicts that there will be more than 100,000 deaths from #LungCancer this year. When lung cancer is found at an earlier stage before it spreads, it’s more likely to be treated successfully. That’s why it’s so important that more individuals get screened – even if they may not be experiencing symptoms. At On Target, we’re committed to helping patients and doctors fight this disease. Our targeted intraoperative molecular imaging agent helps surgeons visualize early-stage lung cancer, remove more cancer during surgery, and contributes to a world with better #LungHealth. #WLCD24   To learn more about our intraoperative molecular imaging agent and risk related information, please visit https://bit.ly/3yr0tVN

Mr Sheng Qiu is a Consultant Colorectal and General Surgeon with a special interest in advanced and complex colorectal cancer. Mr Qiu has experience in pelvic exenteration surgery for locally advanced and recurrent rectal cancers. He also works with liver surgeons performing simultaneous bowel and liver resections, treating patients with metastatic colorectal cancer. Mr Qiu's research interests include novel biomarkers in cancer, personalisation of cancer treatment, and the consequences of colorectal cancer treatment. Read his full profile: https://bit.ly/3U3Lo58 #LikeNoOther #BowelCancerAwarenessMonth

Hello LinkedIn community Brain cancer is a serious condition characterized by the uncontrolled growth of cells within the brain. It can originate in the brain (primary brain cancer) or spread from other parts of the body (secondary, or metastatic, brain cancer). Primary brain tumors can be benign (non-cancerous) or malignant (cancerous), with gliomas and meningiomas being among the most common types. Symptoms of brain cancer vary depending on the tumor's size, location, and rate of growth and may include headaches, seizures, cognitive or personality changes, and motor skill impairments. Diagnosis typically involves imaging studies such as MRI or CT scans, and treatment options include surgery, radiation therapy, and chemotherapy. Advances in medical research are continuously improving the understanding and management of brain cancer, offering hope for better outcomes for patients. #snsinstitutions #snsdesignthinker #designthinking